ARCHIVES

DCE Board Approves Epidemiology Contract Recompetitions

This article is from The Cancer Letter archive.

Vol. 21 No. 11 | March 17, 1995

Download PDF Visit The Full Archive

Related Articles

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

Chronobiology Review Still Delayed

May 5, 1989

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

ASCO Places Ad To Urge Increase In Research Funding.

June 13, 2008

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006

RFAs Available.

July 4, 2003